Coronavirus: WHO recommends second dose of vaccine within 21-28 days

The World Health Organization (WHO) on Tuesday recommended that the required second dose of Pfizer-BioNTech’s Covid-19 vaccine be administered within 21 to 28 days, but … Read more

Coronavirus: The United Kingdom still posts a record of contaminations

Customers line up outside a supermarket in London. The UK reported a record daily COVID-19 infections on Tuesday, as the country battles an upsurge in … Read more

WHO hails ‘phenomenal’ promise of COVID-19 vaccines

By Stephanie Nebehay, John Miller The promise of COVID-19 vaccines is “phenomenal” and “potentially revolutionary,” the European director of the World Health Organization (WHO) said … Read more

Biden credited with 273 voters versus 234 for Trump, according to Edison Research

WASHINGTON (Reuters) – Democratic candidate Joe Biden is credited with 273 electorate voters compared to incumbent President Donald Trump’s 234, according to the latest Edison … Read more

Biden credited with 273 voters versus 234 for Trump, according to Edison Research

WASHINGTON (Reuters) – Democratic candidate Joe Biden is credited with 273 electorate voters compared to incumbent President Donald Trump’s 234, according to the latest Edison … Read more

Biden credited with 253 voters versus 214 for Trump, according to Edison Research

WASHINGTON (Reuters) – Democratic candidate Joe Biden is credited with 253 voters versus 214 for incumbent Republican President Donald Trump, according to the latest Edison … Read more

Biden credited with 224 voters against 213 for Trump – Edison Research

WASHINGTON (Reuters) – Democratic candidate Joe Biden is credited with 224 major voters compared to incumbent Republican President Donald Trump’s 213, according to the latest … Read more

Coronavirus: Promising results for a Chinese vaccine candidate

One of the potential vaccines developed in China against the coronavirus was found to be safe and triggered immune responses in the first two phases … Read more

Coronavirus: Promising results for a Chinese vaccine candidate

One of the potential vaccines developed in China against the coronavirus was found to be safe and triggered immune responses in the first two phases … Read more

Coronavirus-Remdesivir does not shorten healing times, says WHO

GENEVA, Oct. 16 (Reuters) – Remdesivir, the experimental antiviral from the US laboratory Gilead, has little or no effect on the length of hospital stay … Read more